Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical imaging"
DOI: 10.1016/j.clinimag.2020.02.006
Abstract: Immune checkpoint inhibitors are monoclonal antibodies directed against cellular pathways on T-cells to treat different types of malignancies. This new therapy can cause immune-related adverse events that can involve almost any organ system. This article…
read more here.
Keywords:
immune related;
effects checkpoint;
related adverse;
adverse effects ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "British journal of pharmacology"
DOI: 10.1111/bph.70195
Abstract: Immune checkpoint inhibitors (ICIs) improve cancer outcomes but are also associated with immune‐related adverse events (irAEs), which pose significant challenges for clinical management.
read more here.
Keywords:
toxic effects;
decoding fatal;
checkpoint inhibitor;
effects checkpoint ... See more keywords